100
Participants
Start Date
February 9, 2002
Primary Completion Date
January 23, 2007
Study Completion Date
LAMIVUDINE
GSK Clinical Trials Call Center, Tehran
Lead Sponsor
ViiV Healthcare
INDUSTRY